Machine Learning-Devised Immune-Related lncRNA Signature Panel Predicts the Prognosis and Immune Landscape in Breast Cancer Novel IRLP Signature in BRCA

Figure 4

IRLP signature for prognosis prediction of the patient with BRCA. RS (a) and survival outcome (b) of patients with breast cancer are shown. Patients in the low-risk group experienced a longer survival time in all subtypes.

(a)

(b)

(c)

(d)

(e)

(f)